Canbisol

From WikiMD's WELLNESSPEDIA

Canbisol is a synthetic cannabinoid that was developed in the 1970s. It is a non-psychoactive compound, meaning it does not produce the "high" associated with cannabis. Canbisol has been studied for its potential therapeutic uses, particularly in the treatment of glaucoma and epilepsy.

History[edit]

Canbisol was first synthesized in the 1970s by a team of researchers at the University of Mississippi. The team was led by Dr. Raphael Mechoulam, a renowned chemist known for his work on cannabinoids. The goal of the research was to create a synthetic cannabinoid that could be used for medical purposes without the psychoactive effects of cannabis.

Structure and Properties[edit]

Canbisol is a synthetic cannabinoid, meaning it is not naturally occurring but is chemically similar to the cannabinoids found in the cannabis plant. It is a non-psychoactive compound, which means it does not produce the "high" associated with cannabis use. This makes it a potential candidate for therapeutic uses where the psychoactive effects of cannabis are not desired.

Medical Uses[edit]

Canbisol has been studied for its potential therapeutic uses. It has been found to be particularly effective in the treatment of glaucoma, a condition that causes increased pressure in the eye and can lead to vision loss. Canbisol works by reducing intraocular pressure, helping to prevent damage to the optic nerve.

In addition to its use in treating glaucoma, Canbisol has also been studied for its potential use in treating epilepsy. Some studies have found that it can reduce the frequency and severity of seizures in some patients.

Legal Status[edit]

The legal status of Canbisol varies by country. In some countries, it is classified as a controlled substance, while in others it is legal for medical use. It is important to check the laws in your specific location before using Canbisol.

See Also[edit]

This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Canbisol[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Canbisol&oldid=6493047"